Similar articles for PMID: 24797262

Year	Number of Results
2003	2
2004	2
2005	2
2006	3
2007	4
2008	7
2009	5
2010	6
2011	7
2012	6
2013	4
2014	10
2015	3
2017	1
2018	1
2024	0

1

Identification of serum cytokine profiles associated with HBeAg seroconversion following antiviral treatment interruption.

Chokshi S, Cooksley H, Riva A, Phillips S, Williams R, Gaggar A, Naoumov NV. Chokshi S, et al. Viral Immunol. 2014 Jun;27(5):235-44. doi: 10.1089/vim.2014.0022. Epub 2014 May 5. Viral Immunol. 2014. PMID: 24797262 Clinical Trial.

2

[Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].

Ling N, Zhou Z, Zhang DZ, Ren H. Ling N, et al. Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):346-9. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17524266 Clinical Trial. Chinese.

3

Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss.

Zheng Q, Zhu YY, Chen J, Liu YR, You J, Dong J, Zeng DW, Gao LY, Chen LH, Jiang JJ. Zheng Q, et al. J Viral Hepat. 2014 Dec;21(12):909-16. doi: 10.1111/jvh.12261. Epub 2014 Jun 1. J Viral Hepat. 2014. PMID: 24888640

4

Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?

You H, Wu X, Ou X, Ma H, Wang Q, Liu T, Cong M, Wang P, Wang B, Jia J. You H, et al. Antivir Ther. 2011;16(3):299-307. doi: 10.3851/IMP1758. Antivir Ther. 2011. PMID: 21555812

5

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Brosgart CL, Borroto-Esoda K, Arterburn S, Chuck SL; Adefovir Dipivoxil 438 Study Group. Hadziyannis SJ, et al. Gastroenterology. 2006 Dec;131(6):1743-51. doi: 10.1053/j.gastro.2006.09.020. Epub 2006 Sep 20. Gastroenterology. 2006. PMID: 17087951 Clinical Trial.

6

HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during adefovir dipivoxil therapy.

Tseng KC, Cheng PN, Wu IC, Chang CK, Chou AL, Liu WC, Chang TT. Tseng KC, et al. Hepatogastroenterology. 2009 May-Jun;56(91-92):813-8. Hepatogastroenterology. 2009. PMID: 19621708 Clinical Trial.

7

[The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B].

Xie DY, Lin BL, Xu QH, Chen YM, Lu WL, Li JG, Gao ZL. Xie DY, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 May;16(5):341-4. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18510844 Chinese.

8

Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.

Yoon SK, Seo YB, Im SJ, Bae SH, Song MJ, You CR, Jang JW, Yang SH, Suh YS, Song JS, Kim BM, Kim CY, Jeong SH, Sung YC. Yoon SK, et al. Liver Int. 2015 Mar;35(3):805-15. doi: 10.1111/liv.12530. Epub 2014 Mar 29. Liver Int. 2015. PMID: 24620920 Clinical Trial.

9

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F; Club Epatologi Ospedalieri (CLEO) Group. Pellicelli AM, et al. Clin Ther. 2008 Feb;30(2):317-23. doi: 10.1016/j.clinthera.2008.02.012. Clin Ther. 2008. PMID: 18343270

10

[Relationship between HBeAg seroconversion with genotypes and HBV specific CTL in patients with chronic hepatitis B treated with Adefovir dipivoxil].

Zhou YL, Wang XC, Wu YT, Tan YF, Zhao YP, Tang JM, Pan JQ, Yang ZX, Gu XB. Zhou YL, et al. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Jun;25(3):220-3. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011. PMID: 21977598 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year